Dinney C - Search Results

1

Assessment of Luminal and Basal Phenotypes in Bladder Cancer.

Guo CC, Bondaruk J, Yao H, Wang Z, Zhang L, Lee S, Lee JG, Cogdell D, Zhang M, Yang G, Dadhania V, Choi W, Wei P, Gao J, Theodorescu D, Logothetis C, Dinney C, Kimmel M, Weinstein JN, McConkey DJ, Czerniak B. Guo CC, et al. Among authors: dinney c. Sci Rep. 2020 Jun 16;10(1):9743. doi: 10.1038/s41598-020-66747-7. Sci Rep. 2020. PMID: 32546765 Free PMC article.

2

Lymphoepithelioma of the bladder: a clinicopathological study of 3 cases.

Dinney CP, Ro JY, Babaian RJ, Johnson DE. Dinney CP, et al. J Urol. 1993 Apr;149(4):840-1. doi: 10.1016/s0022-5347(17)36228-6. J Urol. 1993. PMID: 8455255

3

Optimal delivery of perioperative chemotherapy: preliminary results of a randomized, prospective, comparative trial of preoperative and postoperative chemotherapy for invasive bladder carcinoma.

Logothetis C, Swanson D, Amato R, Banks M, Finn L, Ayala A, Ro J, Babaian R, Dinney C, Ellerhorst J, Hall C, von Eschenbach A. Logothetis C, et al. Among authors: dinney c. J Urol. 1996 Apr;155(4):1241-5. doi: 10.1016/s0022-5347(01)66230-x. J Urol. 1996. PMID: 8632540 Clinical Trial.

4

Prognostic value of p53 in muscle-invasive bladder cancer treated with preoperative radiotherapy.

Wu CS, Pollack A, Czerniak B, Chyle V, Zagars GK, Dinney CP, Hu SX, Benedict WF. Wu CS, et al. Among authors: dinney cp. Urology. 1996 Mar;47(3):305-10. doi: 10.1016/s0090-4295(99)80443-9. Urology. 1996. PMID: 8633392 Clinical Trial.

5

Retinoblastoma protein expression and radiation response in muscle-invasive bladder cancer.

Pollack A, Czerniak B, Zagars GK, Hu SX, Wu CS, Dinney CP, Chyle V, Benedict WF. Pollack A, et al. Among authors: dinney cp. Int J Radiat Oncol Biol Phys. 1997 Oct 1;39(3):687-95. doi: 10.1016/s0360-3016(97)00147-8. Int J Radiat Oncol Biol Phys. 1997. PMID: 9336151

6

Treatment of human metastatic transitional cell carcinoma of the bladder in a murine model with the anti-vascular endothelial growth factor receptor monoclonal antibody DC101 and paclitaxel.

Inoue K, Slaton JW, Davis DW, Hicklin DJ, McConkey DJ, Karashima T, Radinsky R, Dinney CP. Inoue K, et al. Among authors: dinney cp. Clin Cancer Res. 2000 Jul;6(7):2635-43. Clin Cancer Res. 2000. PMID: 10914704

7

Differential expression of progression-related genes in the evolution of superficial to invasive transitional cell carcinoma of the bladder.

Izawa JI, Slaton JW, Kedar D, Karashima T, Perrotte P, Czerniak B, Grossman HB, Dinney CP. Izawa JI, et al. Among authors: dinney cp. Oncol Rep. 2001 Jan-Feb;8(1):9-15. doi: 10.3892/or.8.1.9. Oncol Rep. 2001. PMID: 11115562

8

Paclitaxel enhances the effects of the anti-epidermal growth factor receptor monoclonal antibody ImClone C225 in mice with metastatic human bladder transitional cell carcinoma.

Inoue K, Slaton JW, Perrotte P, Davis DW, Bruns CJ, Hicklin DJ, McConkey DJ, Sweeney P, Radinsky R, Dinney CP. Inoue K, et al. Among authors: dinney cp. Clin Cancer Res. 2000 Dec;6(12):4874-84. Clin Cancer Res. 2000. PMID: 11156247

9

Radical cystectomy for invasive bladder cancer in the octogenarian.

Lance RS, Dinney CP, Swanson D, Babaian RJ, Pisters LL, Palmer LJ, Grossman HB. Lance RS, et al. Among authors: dinney cp. Oncol Rep. 2001 Jul-Aug;8(4):723-6. doi: 10.3892/or.8.4.723. Oncol Rep. 2001. PMID: 11410772

10

Adenoviral-mediated gene therapy of human bladder cancer with antisense interleukin-8.

Inoue K, Wood CG, Slaton JW, Karashima T, Sweeney P, Dinney CP. Inoue K, et al. Among authors: dinney cp. Oncol Rep. 2001 Sep-Oct;8(5):955-64. doi: 10.3892/or.8.5.955. Oncol Rep. 2001. PMID: 11496299

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

468 results

Search Page

Filters